JournalsHub
.online
Find My Journal
LC

Luana Calabrò

University of Ferrara IT

ORCID 0000-0002-3044-0889
162
Publications
6,864
Citations
40
H-Index
76
i10-Index
4.81
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

162 total

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study

Fabrice Barlési, Johan Vansteenkiste, David R. Spigel, Hidenobu Ishii, Marina Chiara Garassino et al. - The Lancet Oncology, 2018
Cited by 396 OpenAlex

Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study

Luana Calabrò, Aldo Morra, Diana Giannarelli, Giovanni Amato, Armida D’Incecco et al. - The Lancet Respiratory Medicine, 2018
Cited by 215 OpenAlex

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial

Michele Maio, Arnaud Scherpereel, Luana Calabrò, Joachim G.J.V. Aerts, S. Cedrés et al. - The Lancet Oncology, 2017
Cited by 423 OpenAlex

Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study

Luana Calabrò, Aldo Morra, Ester Fonsatti, Ornella Cutaia, Carolina Fazio et al. - The Lancet Respiratory Medicine, 2015
Cited by 203 OpenAlex

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

Luana Calabrò, Aldo Morra, Ester Fonsatti, Ornella Cutaia, Giovanni Amato et al. - The Lancet Oncology, 2013
Cited by 353 OpenAlex

High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients PDF

Mariantonia Logozzi, Angelo De Milito, Luana Lugini, Martina Borghi, Luana Calabrò et al. - PLoS ONE, 2009
Cited by 962 OpenAlex

Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases PDF

Anna Maria Di Giacomo, Riccardo Danielli, Massimo Guidoboni, Luana Calabrò, Dora Carlucci et al. - Cancer Immunology Immunotherapy, 2009
Cited by 276 OpenAlex

Research Topics

Cancer Immunotherapy and Biomarkers (81) Occupational and environmental lung diseases (43) Immunotherapy and Immune Responses (29) CAR-T cell therapy research (28) Pleural and Pulmonary Diseases (17)

Affiliations

University of Siena
IT 2022 - 2005
Università Cattolica del Sacro Cuore
IT 2009 - 2009
University of Messina
IT 2015 - 1998
University of Ferrara
IT 2025 - 2022
Heidelberg University
DE 2015 - 2015

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now